Sign in

CIK 0001582554

  • Non-accelerated filer
  • Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463011414
Phone
+1 908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-12-15 Matkovits Theresa Chief Development Officer Grant or award · Stock Option (right to Buy) +1,300,000 1,300,000
2022-12-20 Matkovits Theresa Chief Development Officer Grant or award · Stock Option (right to Buy) +625,000 625,000
2021-12-14 Matkovits Theresa Chief Development Officer Grant or award · Stock Option (right to Buy) +500,000 500,000
2021-01-01 Matkovits Theresa Chief Development Officer Grant or award · Stock option (right to buy) +425,000 425,000
2020-06-17 Matkovits Theresa Chief Development Officer Grant or award · Stock option (right to buy) +175,000 175,000
2020-01-01 Matkovits Theresa Chief Development Officer Grant or award · Stock option (right to buy) +350,000 350,000
2019-02-11 Matkovits Theresa Chief Development Officer Grant or award · Option (right to buy) +350,000 350,000
2018-10-15 Matkovits Theresa Chief Development Officer Grant or award · Option (right to buy) +350,000 350,000

Page 1 of 1 · 8 trades